abstract |
The invention relates to implants, in particular, for intracavernous or intravascular application, preferably for the treatment or prophylaxis of coronary or peripheral vascular constriction or occlusion, in particular constriction and stenoses or restenoses, preferably for the prophylaxis of restenoses, comprising FK506 in a chemically covalently or non-covalently bonded or physically fixed form, a method for production and use thereof. |